[sentNum: 1]Malignant neoplasm of breast // Aspects of disease screening // Published Comment // International Agency for Research on Cancer // Working Group // 
[sentNum: 2]Editor // Report (document) // International Agency for Research on Cancer // Issue (document) // 1+ Score // Negation // Representation (action) // Consensus // 
[sentNum: 3]Journalist // Reporting // Question (inquiry) // Screening for malignant neoplasm of breast // Scientific Publication // Major medical // Journal // Negation // Including (qualifier) // Laboratory Order Panels // 
[sentNum: 4]Reduction - action // Relationships // Mortality Vital Statistics // Young // Female Breast Carcinoma // Never (frequency) // Exposure to // Aspects of disease screening // Screening - procedure intent // Age // Group 2 // 
[sentNum: 5]Norway // Denmark // Reduction - action // Malignant neoplasm of breast // Relationships // Mortality Vital Statistics // Similarity // Geographic Locations // Introduces // Aspects of disease screening // Early // Introduces // Late // 
[sentNum: 6]Better // Therapeutic procedure // Negation // Aspects of disease screening // Science of Etiology // Most // Reduction - action // 
[sentNum: 7]International Agency for Research on Cancer // Estimated // Plant Leaves // No effect // Treatment room // 
[sentNum: 8]Effect // incidence of cases // Visible // Population Statistics // Leading // Uncompensated // Increase // Malignant neoplasm of breast // incidence of cases // To // year // Aspects of disease screening // 
[sentNum: 9]overdiagnosis // Cancer Detection // Negation // Science of Etiology // Cessation of life // Symptoms // 
[sentNum: 10]Benefits // Trial Screening // Invisible // Population Statistics // Major // apparent // 
[sentNum: 11]International Agency for Research on Cancer // Modeling // Case-Control Studies // Providing (action) // Evidence of // Reduced // Mortality Vital Statistics // Small // overdiagnosis // Negation // Compatible // Observed // Data // Reliability of Results // Clinical Trials, Randomized // 
[sentNum: 12]Editor // Report (document) // Sufficient // Evidence of // Screening mammography // Woman // Age-Years // Malignant neoplasm of breast // Relationships // Mortality Vital Statistics // 
[sentNum: 13]Singular // One // Nine // Screening mammography // Clinical Trials // Reviewed // Swedish // Two // County // Clinical Trials // Including (qualifier) // Woman // Senility // year // SLC33A1 gene // Study // Entry (data) // 
[sentNum: 14]Swedish // Two // County // Clinical Trials // Woman // /40 // Age-Years // Entry (data) // Subset Analysis // Failed // To // Show // Reduced // Specific qualifier value // Mortality Vital Statistics // Female Breast Carcinoma // Screening - procedure intent // Groups // Age-Years // Entry (data) // 
[sentNum: 15]Mammography finding // Disease Screening // Rate // overdiagnosis // Old // Woman // overdiagnosis // Lead // Therapeutic procedure // AN 3 // Mortality, Excess // Therapeutic procedure // Relationships // 
[sentNum: 16]Absence (morphologic abnormality) // Clear // Benefits // Reduced // Malignant neoplasm of breast // Specific qualifier value // Mortality Vital Statistics // Given name // Potential // Increasing // Therapeutic procedure // Relationships // Mortality Vital Statistics // Screening mammography // Woman // Senility // year // Experimental Result // Small // Increase // Science of Etiology // Mortality Vital Statistics // 
[sentNum: 17]Screening mammography // Negation // Recommendation // Woman // Senility // year // 
[sentNum: 18]Editor // International Agency for Research on Cancer // Working Group // Positive Finding // View // Screening mammography // 
[sentNum: 19]User Group // Benefits // Screening mammography // Relative // Term (temporal) // Referring // Absolute // Term (temporal) // 
[sentNum: 20]Conclusion // More // apparent // Result // Absolute // Term (temporal) // 
[sentNum: 21]Result // Include (action) // Malignant neoplasm of breast // Relationships // Mortality Vital Statistics // % of total // Mortality Vital Statistics // False Positive // overdiagnosis // 
[sentNum: 22]Previous // Estimated // Benefits // Mammography // Light Emitting Diode Device Component // Conclusion // Reticular // Benefits // Marginal (quality) // best (quality) // 
[sentNum: 23]Journalist // member // International Agency for Research on Cancer // Working Group // Choose (action) // Basis - conceptual entity // Study Subject // expertise // Absence (morphologic abnormality) // Actual // apparent // Conflict of Interest // 
[sentNum: 24]Used by // Publications // Search - action // To // Scientist // Scientific Publication // Research Activities // Relationships // Intervention regimes // Reviewed // Including (qualifier) // Randomized Controlled Trials as Topic // Question (inquiry) // utilization qualifier // Malignant neoplasm of breast // Disease Screening // 
[sentNum: 25]Working Group // Including (qualifier) // Screen techniques // And // Epidemiology, Descriptive // risk factors // Therapeutic procedure // Malignant neoplasm of breast // 
[sentNum: 26]Geographic // Diversity // consider // 
[sentNum: 27]Randomization // Controlled Clinical Trials as Topic // Reviewed // To // Evaluation // Efficacy Study // Negation // Effectiveness // Screening mammography // 
[sentNum: 28]Evidence of // Clinical Trials, Randomized // Relevance // Today (temporal qualifier) // Dietary Supplements // evaluation of evidence // Current (present time) // Services // Disease Screening // 
[sentNum: 29]Within // Evaluation // Screening mammography // Value Above Reference Range // Quality // Cohort Studies // consider // To // Providing (action) // Most // Informative // Data // 
[sentNum: 30]Working Group // Give - dosing instruction imperative // Most // Weighing patient // Scientific Study // Long // Follow-Up Report // Period (temporal qualifier) // Most // Robust // Design // Account number:Identifier:Point in time:^Patient:Nominal // Lead // Time // Temporal -Temporal Qualifier // geographic difference // Screening - procedure intent // Participant // Control function // Individuality // Relationships // Primary operation // Result // 
[sentNum: 31]Scientific Study // Account number:Identifier:Point in time:^Patient:Nominal // Outcome of Therapy // overdiagnosis // Design // 
[sentNum: 32]Add - instruction imperative // Working Group // Evaluation // Potential // overdiagnosis // Conclude Resin // Sufficient // Evidence of // overdiagnosis // Woman // Screening - procedure intent // Arabic numeral 69 // Age-Years // 
[sentNum: 33]Case-Control Studies // Design // Account number:Identifier:Point in time:^Patient:Nominal // Before // Factor // consider // Result // Line Specimen // Cohort Studies // 
[sentNum: 34]Ecology // Scientific Study // Comparison // Mortality Vital Statistics // Geographic Locations // Time periods // Judge // To // Negation // control aspects // Potential // secular trend // Population Characteristics // 
[sentNum: 35]Modeling // Scientific Study // Negation // consider // Evaluation // 
[sentNum: 36]Working Group // Used by // Same // Outcome Measures // Including (qualifier) // Malignant neoplasm of breast // Relationships // Mortality Vital Statistics // overdiagnosis // Measures // Basis - conceptual entity // Mortality Vital Statistics // Scientific Study // 
[sentNum: 37]Aftercare // Assessment of sense of balance // Benefits // Adverse effects // Screening mammography // Working Group // Conclude Resin // Reticular // Benefits // Woman // To // Arabic numeral 69 // Age-Years // Receive // Disease Screening // 
[sentNum: 38]Add - instruction imperative // Incidence Studies // Basis - conceptual entity // Cohort // Mortality Vital Statistics // Reporting // Risk Reduction // Cessation of life // From // Female Breast Carcinoma // Offered // Screening mammography // Age-Years // 
